Availability of mifepristone and misoprostol in Oregon pharmacies: A comparison by rural and urban status.
Contraception
; : 110491, 2024 May 18.
Article
en En
| MEDLINE
| ID: mdl-38763275
ABSTRACT
OBJECTIVES:
To evaluate the availability of mifepristone and misoprostol at pharmacies in a state with protective abortion legislation and variation in access by rurality. STUDYDESIGN:
Using a secret shopper survey, researchers attempted to contact all community pharmacies in Oregon and evaluate their mifepristone and misoprostol provisions.RESULTS:
Among the 444 pharmacies surveyed, mifepristone was planned at 19.2%. Misoprostol was available at 77.5%, but stocking issues and medication ordering impact access, without significant differences by rurality.CONCLUSIONS:
Pharmacy engagement and support are key to increasing access to these essential medicines, which may be improved through education and referral programs.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Contraception
Año:
2024
Tipo del documento:
Article